lbl-007
Showing 1 - 6 of 6
Esophageal Cancer, Esophageal Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (LBL-007,
Not yet recruiting
- Esophageal Cancer
- +2 more
- LBL-007
- +2 more
- (no location specified)
Aug 21, 2023
Advanced Melanoma Trial in China (LBL-007, Toripalimab, Axitinib Tablets)
Recruiting
- Advanced Melanoma
- LBL-007
- +2 more
-
Beijing, Beijing, China
- +7 more
Jan 9, 2023
Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer Trial in Australia, China
Recruiting
- Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer
- LBL-007
- +3 more
-
Benowa, Queensland, Australia
- +7 more
Jan 30, 2023
Head and Neck Squamous Cell Carcinoma, Head Neck Cancer Trial (Tislelizumab, BGB-A425, LBL-007)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Head and Neck Cancer
- Tislelizumab
- +2 more
- (no location specified)
Jun 9, 2023
Non Small Cell Lung Cancer Trial (Tislelizumab, Ociperlimab, LBL-007)
Not yet recruiting
- Non Small Cell Lung Cancer
- Tislelizumab
- +2 more
- (no location specified)
Jan 30, 2023
NSCLC, Metastatic NSCLC Trial (Tislelizumab, BGB-A445, LBL-007)
Not yet recruiting
- Non-small Cell Lung Cancer
- Metastatic Non-small Cell Lung Cancer
- Tislelizumab
- +7 more
- (no location specified)
Dec 14, 2022